Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytta (CYCA) EBITDA (2020 - 2025)

Cytta's EBITDA history spans 11 years, with the latest figure at -$372968.0 for Q2 2025.

  • For Q2 2025, EBITDA rose 71.2% year-over-year to -$372968.0; the TTM value through Jun 2025 reached $891327.0, up 114.04%, while the annual FY2024 figure was -$3.9 million, 15.87% up from the prior year.
  • EBITDA for Q2 2025 was -$372968.0 at Cytta, up from -$579417.0 in the prior quarter.
  • Across five years, EBITDA topped out at $3.7 million in Q2 2023 and bottomed at -$6.6 million in Q3 2023.
  • The 5-year median for EBITDA is -$802509.5 (2024), against an average of -$590954.1.
  • The largest YoY upside for EBITDA was 417.27% in 2023 against a maximum downside of 433.63% in 2023.
  • A 5-year view of EBITDA shows it stood at -$1.1 million in 2021, then grew by 1.55% to -$1.1 million in 2022, then surged by 322.16% to $2.4 million in 2023, then rose by 3.99% to $2.5 million in 2024, then crashed by 114.67% to -$372968.0 in 2025.
  • Per Business Quant, the three most recent readings for CYCA's EBITDA are -$372968.0 (Q2 2025), -$579417.0 (Q1 2025), and $2.5 million (Q4 2024).